GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Land And Improvements

Moss Genomics (XCNQ:MOSS) Land And Improvements : C$0.00 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Land And Improvements?

Moss Genomics's land and improvements for the quarter that ended in Mar. 2025 was C$0.00 Mil.


Moss Genomics Land And Improvements Historical Data

The historical data trend for Moss Genomics's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Land And Improvements Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Land And Improvements
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Moss Genomics Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Hunter Jordan Director
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines